Savient Pharmaceuticals earlier this month received positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use recommending approval of a marketing authorization in the European Union for KRYSTEXXA.
Going forward ... (see research report)
Copyright ® 2013. The Bedford Report. All Rights Reserved.